| 期 |
标题 |
文件 |
| 卷 8, 编号 1 (2020) |
MEMBERS OF THE FAMILY LAMIACEAE LINDL. AS SOURCES OF MEDICINAL PLANT RAW MATERIALS TO OBTAIN NEUROTROPIC DRUGS |
(Rus)
|
|
Zvezdina E., Dayronas Z., Bochkareva I., Zilfikarov I., Babaeva E., Ferubko E., Guseynova Z., Serebryanaya F., Kaibova S., Ibragimov T.
|
| 卷 8, 编号 1 (2020) |
RESULTS OF A COMPARATIVE STUDY OF NIGELLA SATIVA L. SEEDS OILS COMPOSITION |
(Rus)
|
|
Goryainov S., Khromov A., Bakureza G., Cesar E., Ivlev V., Vorobyev A., Abramovich R., Potanina O., Novikov O.
|
| 卷 8, 编号 1 (2020) |
HPLC METHODS OF FEXOFENADINE QUANTITATIVE ANALYSIS IN RABBITS’ LIVER |
(Rus)
|
|
Mylnikov P., Chernykh I., Shchulkin A., Popova N., Yakusheva E.
|
| 卷 8, 编号 2 (2020) |
Antitrombotic activity of a new benzimidazole derivative with a spatially difficult phenolic substitute in its structure |
(Rus)
(Eng)
|
|
Spasov A., Kucheryavenko A., Gaidukova K., Chernikov M., Zhukovskaya O.
|
| 卷 8, 编号 1 (2020) |
BETAMETHASONE ADMINISTRATION AS A TREATMENT OF CHOICE IN LOCAL POST-TATTOO COMPLICATIONS |
(Rus)
|
|
Karymov O., Vorobyov A., Kalashnikova S., Polyakova L., Vyskub M.
|
| 卷 8, 编号 2 (2020) |
Complex biostimulation of intrapleural adhesiogenesis in thoracal surgery |
(Rus)
(Eng)
|
|
Kalashnikov A., Vorobiev A., Kalashnikova S., Salimov D.
|
| 卷 8, 编号 2 (2020) |
study of antiatherosclerotic and endothelioprotective activity of peptide agonists of EPOR/CD131 heteroreceptor |
(Rus)
|
|
Puchenkova O., Nadezhdin S., Soldatov V., Zhuchenko M., Korshunova D., Kubekina M., Korshunov E., Korokina L., Golubinskaya P., Kulikov A., Gureev V., Pokrovskiy V., Patrakhanov E., Lebedev P., Denisyuk T., Belyaeva V., Movchan E., Lepetukha E., Pokrovskiy M.
|
| 卷 8, 编号 1 (2020) |
RETROSPECTIVE ANALYSIS OF ADVERSE DRUG REACTION REPORTING FORMS ASSOCIATED WITH PENICILLIN FAMILY ANTIBIOTICS (PCNE-DRP 9.0) BASED ON DRUG-RELATED APPROACH |
(Rus)
|
|
Matveev A., Krasheninnikov A., Egorova E., Koniaeva E.
|
| 卷 8, 编号 2 (2020) |
Using quantum-chemical parameters for predicting anti-radical (HO∙) activity of related structures containing a cinnamoyl fragment II. derivatives of 2’,4’-dihydroxychalcone, flavanone and flavone, containing a hydroxy group in position 7 |
(Rus)
|
|
Oganesyan E., Shatokhin S.
|
| 卷 8, 编号 1 (2020) |
PROBLEMS OF PHARMACEUTICAL PROVISION OF POPULATION WITH HYPOLIPIDEMIC DRUGS: THE CASE OF THE VOLGOGRAD REGION (THE RUSSIAN FEDERATION) |
(Rus)
|
|
Tyurenkov I., Knyazeva J., Ganicheva L., Kaysheva N.
|
| 卷 8, 编号 2 (2020) |
Films in Russian medicine and cosmetology: development history, classification, technology |
(Rus)
|
|
Kishchenko V., Vernikovsky V., Privalov I., Shevchenko A.
|
| 卷 8, 编号 3 (2020) |
Efficacy and safety of some etiotropic therapeutic schemes for treating patients with novel coronavirus infection (COVID-19) |
(Rus)
(Eng)
|
|
Balykova L., Pavelkina V., Shmyreva N., Pyataev N., Selezneva N., Shepeleva O., Almyasheva R.
|
| 卷 8, 编号 3 (2020) |
Clinical-immunological effectiveness of ribomunyl in children with virus-induced bronchial asthma |
(Rus)
(Eng)
|
|
Belan E., Nikiforova E., Zayachnikova T., Shishimorov I., Magnitskaya O.
|
| 卷 8, 编号 2 (2020) |
Chemical constituents of Geum rivale L. and their biological activity |
(Rus)
|
|
Orlova A., Povydysh M.
|
| 卷 8, 编号 3 (2020) |
Additive neuroprotective effect of 3-hydroxypyridine derivatives and human erythropoetin analogue on a hemorrhagic stroke model in rats |
(Rus)
(Eng)
|
|
Kolesnichenko P., Shcheblykina O., Nesterova N., Shcheblykin D., Nesterov A., Pokrovsky M., Zhuchenko M., Tverskoy A., Reznikov K.
|
| 卷 8, 编号 3 (2020) |
Antibacterial and immunotropic properties of isoliquiritigenin in generalized staphylococcal infection in mice |
(Rus)
(Eng)
|
|
Solyonova E., Pavlova S.
|
| 卷 8, 编号 4 (2020) |
Pharmacodynamics of oral anticoagulants in patients with atrial fibrillation in the acute period of ischemic stroke |
(Rus)
(Eng)
|
|
Petrov V., Gerasimenko A., Gorbatenko V., Shatalova O.
|
| 卷 8, 编号 3 (2020) |
Conceptually-theoretical justification and updating of the preventive approach in the implementation of a pharmacist’s information consultancy services in the public health system |
(Rus)
(Eng)
|
|
Kirshchina I., Soloninina A., Mikhailova V.
|
| 卷 8, 编号 4 (2020) |
Development of a solid dosage form with adsorption activity |
(Rus)
(Eng)
|
|
Chirkova M., Gulyaev D., Chugunova M., Belonogova V.
|
| 卷 8, 编号 4 (2020) |
Study of the stability of the substance 3-[2-(4-phenyl-1- piperazino)-2-oxoethyl]quinazoline-4(3н)-one under stressful conditions |
(Eng)
(Rus)
|
|
Gendugov T., Glushko A., Ozerov A., Shcherbakova L.
|
| 卷 8, 编号 3 (2020) |
Comparative analysis of Lebanon development. Prospects for cooperation with the Russian Federation |
(Rus)
(Eng)
|
|
El Moussawi M., Mironenkova Z., Umarov S., Knysh O., Nemyatykh O.
|
| 卷 8, 编号 4 (2020) |
Estimation of the efficiency of hormone-regulating synchronization of ovulation in female mice |
(Rus)
(Eng)
|
|
Pokrovsky V., Patrakhanov E., Lebedev P., Belashova A., Karagodina A., Shabalin A., Nesterov A., Markovskaya V., Pokrovsky M.
|
| 卷 8, 编号 5 (2020) |
Mumps: achievements, problems and ways of solution |
(Rus)
(Eng)
|
|
Semerikov V., Yuminova N., Postanogova N., Sofronova L.
|
| 卷 8, 编号 4 (2020) |
The search for neuroprotective compounds among new ethylthiadiazole derivatives |
(Eng)
(Rus)
|
|
Cherevatenko R., Antsiferov O., Skachilova S., Pokrovsky M., Gureev V., Banchuk I., Banchuk A., Golubinskaya M., Syromyatnikova A., Rozhkov I., Mostovykh A.
|
| 卷 8, 编号 5 (2020) |
Correction of morphofunctional disorders in experimental preeclampsy by combined use of trimetazidine and purified micronized flavonoid fraction as well as their combinations with methylampsy |
(Eng)
(Rus)
|
|
Antsiferova O., Teleschenko M., Tsuverkalova Y., Pokrovsky M., Gureev V., Zatolokina M., Gureeva A.
|
| 卷 8, 编号 5 (2020) |
Сomparative analysis of drug efficacy in the treatment for COVID-19 severe forms, based on attribute-based statistic methods and analysis of drug interactions |
(Rus)
(Eng)
|
|
Zhukova O., Kagramanyan I., Khokhlov A.
|
| 卷 8, 编号 4 (2020) |
Analysis of the implementation of the federal assurance program of supporting beneficiaries with indispensable medicinal preparations in the subjects of the Russian Federation |
(Rus)
(Eng)
|
|
Petrukhina I., Yagudina R., Ryazanova T., Kurkin V., Pervushkin S., Egorova A., Loginova L., Khusainova A., Blinkova P.
|
| 卷 8, 编号 5 (2020) |
Effect of the GABA derivative succicard on the lipid and carbohydrate metabolism in the offspring of rats with experimental preeclampsia in early and late ontogeny |
(Eng)
(Rus)
|
|
Muzyko E., Perfilova V., Nesterova A., Suvorin K., Tyurenkov I.
|
| 卷 8, 编号 5 (2020) |
Comparative review of methodologies for estimating the cost of adverse drug reactions in the Russian Federation and Brazil |
(Rus)
(Eng)
|
|
Syraeva G., Kolbin A., Matveev A., Panezhina V.
|
| 卷 8, 编号 6 (2020) |
Mechanisms of cytokine storm development in COVID-19 and new potential targets of pharmacotherapy |
(Rus)
(Eng)
|
|
Petrov V., Amosov A., Gerasimenko A., Shatalova O., Ponomareva A., Akinchits A., Kulakova I., Gorbatenko V.
|
| 卷 8, 编号 5 (2020) |
Hemorheological properties of the 5-HT2a-antagonist of the 2-methoxyphenyl-imidazobenzimidazole derivative of the RU-31 compound and cyproheptadine, in comparison with penthoxyphylline |
(Eng)
(Rus)
|
|
Yakovlev D., Naumenko L., Sultanova K., Spasov A.
|
| 卷 8, 编号 6 (2020) |
Pharmacogenetic bases of individual sensitivity and personalized administration of antiplatelet therapy in different ethnic groups |
(Rus)
(Eng)
|
|
Kantemirova B., Orlova E., Polunina O., Chernysheva E., Abdullaev M., Sychev D.
|
| 卷 8, 编号 5 (2020) |
Problems of responsible self-medication of allergy symptoms and farmaceutical counseling |
(Rus)
(Eng)
|
|
Izrafilova V., Egorova S., Garifullina G., Akhmetova T.
|
| 卷 8, 编号 6 (2020) |
Phleboprotectors based on flavonoids: dosage forms, biopharmaceutical characteristics, technological features |
(Rus)
(Eng)
|
|
Stepanova E., Remezova I., Shevchenko A., Morozov A., Maltseva V.
|
| 卷 8, 编号 5 (2020) |
Analysis of industrial practice of drug quality risk management in russian pharmaceutical enterprises |
(Rus)
(Eng)
|
|
Kashirina A., Aladysheva Z., Pyatigorskaya N., Belyaev V., Beregovyh V.
|
| 卷 8, 编号 6 (2020) |
Application of multipotent mesenchymal stem cell secretome in the treatment of adjuvant arthritis and contact-allergic dermatitis in animal models |
(Rus)
(Eng)
|
|
Golubinskaya P., Sarycheva M., Dolzhikov A., Bondarev V., Stefanova M., Soldatov V., Nadezhdin S., Korokin M., Pokrovsky M., Burda Y.
|
| 卷 8, 编号 6 (2020) |
Correction of psychoneurological signs of acute alcohol intoxication in rats with a new acetylcysteine-based composition |
(Rus)
(Eng)
|
|
Kurkin D., Morkovin E., Osadchenko N., Bakulin D., Abrosimova E., Dubrovina M., Kovalev N., Gorbunova Y., Tyurenkov I.
|
| 卷 9, 编号 1 (2021) |
Dendrimers in anticancer targeted drug delivery: accomplishments, challenges and directions for future |
(Rus)
(Eng)
|
|
Amjad M.
|
| 卷 9, 编号 1 (2021) |
Biological activity of Hypericum perforatum L. (Hypericaceae): a review |
(Rus)
(Eng)
|
|
Budantsev A., Prikhodko V., Varganova I., Okovityi S.
|
| 卷 8, 编号 6 (2020) |
Pharmacoeconomic evaluation of anti-pneumococcal vaccination in risk groups for the prevention of community-acquired pneumonia among adults in the Astrakhan region |
(Rus)
(Eng)
|
|
Orlova E., Dorfman I., Orlov M., Abdullaev M.
|
| 卷 9, 编号 1 (2021) |
Pharmaceutical services: status and development trends |
(Rus)
(Eng)
|
|
Klimenkova A., Geller L., Skripko A., Gravchenko L., Korzhavykh E.
|
| 卷 8, 编号 6 (2020) |
Use of quantum-chemical parameters for forecasting antiradical (HO·) activity of related structures containing a cinnamic mold fragment. III. Chalcones, flavanones and flavones with phloroglucinic type of ring “A” |
(Rus)
(Eng)
|
|
Oganesyan E., Shatokhin S.
|
| 卷 9, 编号 1 (2021) |
Approaches to the selection of excipients for dental gel with cetylpyridinium chloride |
(Rus)
(Eng)
|
|
Zagorulko E., Karavaeva A.
|
| 卷 8, 编号 6 (2020) |
Study of pharmaceutical specialists’ information awareness on the matters of drug abuse |
(Rus)
(Eng)
|
|
Porseva N., Soloninina A., Dvorskaya O.
|
| 卷 9, 编号 1 (2021) |
Multisensory colorimetric analysis of drugs dydrogesterone, troxerutin and ademetionine using barcodes |
(Rus)
(Eng)
|
|
Monogarova O., Chaplenko A., Oskolok K.
|
| 卷 9, 编号 1 (2021) |
Study of the safety of antianemic preparations by method of the system of problems related to medicinal preparations |
(Rus)
(Eng)
|
|
Matveev A., Egorova E., Koniaeva E., Bekirova E., Adzhimamutova L.
|
| 卷 8, 编号 6 (2020) |
Life quality assessment of patients with stable coronary artery disease after myocardial revascularization |
(Rus)
(Eng)
|
|
Narkevich I., Nemyatykh O., Kovaleva K., Ratova L., Trushnikova I., Parizhskaya E., Konradi A.
|
| 卷 9, 编号 1 (2021) |
Molecular design of N-acyl derivatives of 2-(2-oxopyrolidin-1-yl)-acetamide with GABA-ergic and glutamatergic activities |
(Rus)
(Eng)
|
|
Kodonidi I., Chiriapkin A., Tworowski D.
|
| 卷 8, 编号 6 (2020) |
Number of runs variations on Autodock 4 do not have a significant effect on RMSD from docking results |
(Rus)
(Eng)
|
|
Pratama M., Siswandono S.
|
| 卷 9, 编号 3 (2021) |
Genetic predictors of severity and efficacy of COVID-19 pharmacotherapy |
(Rus)
(Eng)
|
|
Shishimorov I., Magnitskaya O., Ponomareva Y.
|
| 卷 9, 编号 1 (2021) |
Obituary for Yuri N. Chernov. 5 nov 1937 – 1 jan 2021 |
(Rus)
(Eng)
|
|
Vasin M., Esaulenko I., Kukes V., Petrov V., Ushakov I., Khokhlov A.
|
| 卷 9, 编号 3 (2021) |
Standardization problems of medicinal preparations from Rhodiola rosea L. |
(Rus)
(Eng)
|
|
Kurkin V., Ryazanova T.
|
| 卷 9, 编号 3 (2021) |
Effect of solid dispersions on the solubility of metronidazole |
(Rus)
(Eng)
|
|
Krasnyuk I., Naryshkin S., Krasnyuk I., Belyatskaya A., Stepanova O., Bobrov I., Yankova V., Rau J., Vorobiev A.
|
| 卷 9, 编号 3 (2021) |
Experimental study of toxic properties of VMU-2012-05 drug – original non-nucleeside inhibitor of HIV-1 reverse transcriptase |
(Rus)
(Eng)
|
|
Vavilova V., Shekunova E., Jain E., Balabanyan V., Ozerov A., Makarova M., Makarov V.
|
| 卷 9, 编号 3 (2021) |
Synthesis, antiaggregation and antitrombotic activities of new derivatives of hydroxybenzoic acids with tauric fragment |
(Rus)
(Eng)
|
|
Brel A., Atapina N., Budaeva Y., Lisina S., Tsaruk S., Kurkin D., Tyurenkov I.
|
| 卷 9, 编号 3 (2021) |
Economic aspects of application of the russian biosimilar omalizumab in patients with atopic bronchial asthma of moderate to severe clinical courses |
(Rus)
(Eng)
|
|
Krysanova V., Ermolaeva A., Ermolaeva T., Davydovskaya M., Kokushkin K.
|
| 卷 9, 编号 4 (2021) |
Antitumor drugs based on indolocarbazol derivatives |
(Rus)
(Eng)
|
|
Kolpaksidi A., Dmitrieva M., Yarosh I., Krasnyuk I.
|
| 卷 9, 编号 4 (2021) |
Development and validation of methods for quantitative determination of active pharmaceutical substances in nasal spray |
(Rus)
(Eng)
|
|
Larskiy M., Pozdnyakova A., Khadzhieva Z., Pozdnyakov D.
|
| 卷 9, 编号 4 (2021) |
Effect of cryopreserved placenta extract on some biochemical indices of therapeutic efficiency and toxicity of diclofenac sodium in adjuvant-induced experimental arthritis |
(Rus)
(Eng)
|
|
Hladkykh F., Chyzh M., Manchenko A., Belochkina I., Mikhailova I.
|
| 卷 9, 编号 4 (2021) |
Study of the pharmacological activity of novel EPOR/CD131 heteroreceptor agonists in mice with endothelial-specific expression of mutant Polg gene |
(Rus)
(Eng)
|
|
Korokin M., Kubekina M., Deykin A., Antsiferov O., Pokrovskii V., Korokina L., Kartashkina N., Soldatova V., Kuzubova E., Radchenko A., Pokrovskii M.
|
| 卷 9, 编号 4 (2021) |
Influence of certain d-metals on formation of advanced glycation end products, aggregation and amyloid transformation of albumin in glycation reaction |
(Rus)
(Eng)
|
|
Litvinov R., Gontareva A., Usmiyanova L., Klimenko D.
|
| 卷 9, 编号 4 (2021) |
Antimicrobial activity study of new quinazolin-4(3h)-ones against Staphylococcus aureus and Streptococcus pneumoniae |
(Rus)
(Eng)
|
|
Samotrueva M., Ozerov A., Starikova A., Gabitova N., Merezhkina D., Tsibizova A., Tyurenkov I.
|
| 卷 9, 编号 5 (2021) |
PLGA – the smart polymer for drug delivery |
(Rus)
(Eng)
|
|
Surya N., Bhattacharyya S.
|
| 卷 9, 编号 5 (2021) |
Heat shock protein Hsp70: prerequisites for use as a medicinal product |
(Rus)
(Eng)
|
|
Pokrovsky V., Patrakhanov E., Antsiferov O., Kolesnik I., Belashova A., Soldatova V., Pokopeiko O., Karagodina A., Arkhipov I., Voronina D., Sushkova D.
|
| 卷 9, 编号 5 (2021) |
Methods for quantitative determination of total flavonoids in Quercus robur L. buds |
(Rus)
(Eng)
|
|
Ryabov N., Ryzhov V., Kurkin V.
|
| 卷 9, 编号 5 (2021) |
Synthesis and antioxidant activity of (E)-3-(3-(4-oxo-4H-chromen-3-yl)acryloyl) 2H-chromen-2-one derivatives |
(Rus)
(Eng)
|
|
Shatokhin S., Tuskaev V., Gagieva S., Pozdnyakov D., Oganesyan E.
|
| 卷 9, 编号 6 (2021) |
A few representatives of Asteroidae (Asteraceae) subfamily and Geranium (Geraniaceae) genus in the Baikal region (review) |
(Rus)
(Eng)
|
|
Privalova E.
|
| 卷 9, 编号 5 (2021) |
Type 2 diabetes mellitus’s decompensated form: on the problem of effective pharmacotherapy in real clinical practice |
(Rus)
(Eng)
|
|
Safronenko A., Gantsgorn E., Sanina E., Khachumova M., Panenko S., Kuznetsov I., Kivva A., Polyakova V.
|
| 卷 9, 编号 6 (2021) |
Development of peroral hypolipidemic formulation based on sulfated arabinogalactan in the form of potassium salt |
(Rus)
(Eng)
|
|
Kostyro Y., Alekseev K.
|
| 卷 9, 编号 5 (2021) |
Cost-minimization analysis of using short and long-acting erythropoesis-stimulating agents for correction of nephrogenic anemia against the background of substitution therapy |
(Rus)
(Eng)
|
|
Krysanov I., Ermakova V., Vaskova L., Tiapkina M.
|
| 卷 9, 编号 6 (2021) |
Study of clinical and pathogenetic effects of anti-viral drug based on favipiravir in comorbid patients with COVID-19 at the outpatient stage of treatment |
(Rus)
(Eng)
|
|
Balykova L., Radaeva O., Zaslavskaya K., Kostina Y., Iskandyarova M., Negodnova E., Eremeev V., Sabirov L., Semeleva E.
|
| 卷 9, 编号 6 (2021) |
Clinical and economic justification of software screening performance of colorectal cancer at the region level |
(Rus)
(Eng)
|
|
Petukhova Y., Eliseeva E., Petukhova A.
|
| 卷 9, 编号 5 (2021) |
Antihistamines: research and analysis of the regional retail market |
(Rus)
(Eng)
|
|
Prokopenko V., Kabakova T., Chernikov M., Goryachev A., Mikhailova S., Knysh O.
|
| 卷 9, 编号 6 (2021) |
Antitumor activity in vivo of aqueous and alcoholic extracts of Thymus Marschallianus Willd |
(Rus)
(Eng)
|
|
Sheremetyeva A., Napsheva A., Durnova N.
|
| 卷 10, 编号 1 (2022) |
Current state of research in the field of chemical composition and pharmacological effects of zea maydis styli cum stigmatis |
(Rus)
(Eng)
|
|
Nikiforova E., Bat N., Davitavyan N.
|
| 卷 9, 编号 5 (2021) |
Actual problems of professional and personal development of qualified persons responsible for quality of medicinal products for human use |
(Rus)
(Eng)
|
|
Aladysheva Z., Pyatigorskaya N., Belyaev V., Nikolenko N., Nesterkina E., Loseva S.
|
| 卷 9, 编号 6 (2021) |
Effect of glyprolines on the level of apoptotic and neurotrophic factors under conditions of “social” stress |
(Rus)
(Eng)
|
|
Yasenyavskaya A., Tsibizova A., Andreeva L., Myasoedov N., Bashkina O., Samotrueva M.
|
| 卷 10, 编号 1 (2022) |
Obesity as a reflection of psycho-emotional disorders: focus on pharmacotherapy |
(Rus)
(Eng)
|
|
Shishkova V.
|
| 卷 10, 编号 1 (2022) |
Features of quantitative estimation of flavonoid content in juglans nigra l. barks preparations |
(Rus)
(Eng)
|
|
Kurkin V., Zimenkina N.
|
| 卷 9, 编号 6 (2021) |
Analysis of the personnel’s consistent readiness for changes as illustrated by the example of an export-oriented biotechnological enterprise |
(Rus)
(Eng)
|
|
Kazakova E., Trukhin V., Narkevich I., Basakina I.
|
| 卷 10, 编号 1 (2022) |
Study of organic acids profile of genus Persicaria Mill species |
(Rus)
(Eng)
|
|
Chistyakova A., Gudkova A., Slivkin A., Chupandina E.
|
| 卷 9, 编号 6 (2021) |
Use of sequencing methods for species identification exemplified by phylogenetic relationships within genus Hedysarum L. |
(Rus)
(Eng)
|
|
Imachueva J., Serebryanaya F., Machs E., Kotseruba V.
|
| 卷 10, 编号 1 (2022) |
Development of nitrofuran derivative: composition and technology of effervescent tablets with solid dispersions |
(Rus)
(Eng)
|
|
Elagina A., Belyatskaya A., Krasnyuk I., Krasnyuk I., Stepanova O., Fateeva T., Smolyarchuk E., Kozin S., Plakhotnaya O., Rastopchina O., Rau J.
|
| 卷 10, 编号 1 (2022) |
Application of multivariate anova and generalized desirability to optimize the composition and technology of tablets containing N-benzyl-N-methyl-1-phenylpyrrolo [1,2-a] pyrazine-3-carboxamide |
(Rus)
(Eng)
|
|
Tishkov S., Blynskaya E., Alekseev K., Alekseev V., Gavrilov D.
|
| 卷 10, 编号 1 (2022) |
Pharmacological activity of extracts from plants of cosmos bipinnatus cav. species |
(Rus)
(Eng)
|
|
Kulichenko E., Andreeva O., Sergeeva E., Sigareva S., Terekhov A., Oganesyan E., Sidorskaya S.
|
| 卷 10, 编号 3 (2022) |
Cluster analysis of integrated “drug supply” concept |
(Rus)
(Eng)
|
|
Barkaev G., Kabakova T., Goryachev A.
|
| 卷 10, 编号 3 (2022) |
Phytochemical and microbiological aspects of the Nigella sativa l. herbs study |
(Rus)
(Eng)
|
|
Mubinov A., Kurkin V., Avdeeva E., Kolpakova S., Zhestkov A.
|
| 卷 10, 编号 1 (2022) |
Pharmacotherapy possibilities of cardiovascular autonomous neuropathy in children with type 1 diabetes mellitus at the preclinical stage |
(Rus)
(Eng)
|
|
Malyuzhinskaya N., Shishimorov I., Magnitskaya O., Stepanenko K., Polyakova O., Klitochenko G., Petrova I., Emelyanova S., Skiba A.
|
| 卷 10, 编号 3 (2022) |
Optimization technology of fat-soluble vitamins production based on alkaline hydrolysis |
(Rus)
(Eng)
|
|
Sysuev E., Stepanova E., Noskova V.
|
| 卷 10, 编号 3 (2022) |
Polypharmacy in managment of in-patients with novel coronavirus disease (COVID-19) |
(Rus)
(Eng)
|
|
Petrov V., Ryazanova A., Privaltseva N., Nekrasov D.
|
| 卷 10, 编号 1 (2022) |
Evaluation of ABCB1-protein inhibition prospectiveness in hematoencephalic barrier as method for increasing efficiency of pharmacotherapy in cerebral ischemia |
(Rus)
(Eng)
|
|
Chernykh I., Shchulkin A., Gatsanoga M., Yakusheva E.
|
| 卷 10, 编号 3 (2022) |
Clinical and economic evaluation of atezolizumab + vemurafenib + cobimetinib combination and nivolumab + ipilimumab combination: administration in metastatic melanoma treatment with BRAF-confirmed mutation in adult patients |
(Rus)
(Eng)
|
|
Krysanov I., Makarova E., Ermakova V.
|
| 卷 10, 编号 1 (2022) |
Effectiveness and safety of favipiravir infusion in patients hospitalized with COVID-19 |
(Rus)
(Eng)
|
|
Balykova L., Zaslavskaya K., Pavelkina V., Pyataev N., Selezneva N., Kirichenko N., Ivanova A., Rodoman G., Kolontarev K., Skrupsky K., Simakina E., Mubarakshina O., Taganov A., Pushkar D.
|
| 卷 10, 编号 3 (2022) |
Evaluation of weight reduction efficacy and safety of sibutramin-containing drugs in patients with alimentary obesity |
(Rus)
(Eng)
|
|
Demidova T., Izmailova M., Ushakova S., Zaslavskaya K., Odegova A., Popova V., Nevretdinova M., Verbovoy A., Bely P.
|
| 卷 10, 编号 2 (2022) |
Activity modulation of various nitric oxide syntases as an approach to endothelial dysfunction therapy |
(Rus)
(Eng)
|
|
Kurkin D., Abrosimova E., Bakulin D., Kovalev N., Dubrovina M., Borisov A., Strygin A., Morkovin E., Tyurenkov I.
|
| 卷 10, 编号 2 (2022) |
Minimisation of risks associated with the use of pollen-based medicines, at the stage of pollen collection |
(Rus)
(Eng)
|
|
Taube A., Buyanova T., Sakanyan E.
|
| 卷 10, 编号 2 (2022) |
Comparative pharmacoeconomic analysis of long-acting lanreotide used in acromegaly therapy within conditions of the Russian Federation health care system |
(Rus)
(Eng)
|
|
Krysanov I., Makarova E., Ermakova V.
|
| 卷 10, 编号 2 (2022) |
Gender characteristics of adverse drug reactions development: experience of regional database analysis |
(Rus)
(Eng)
|
|
Matveev A., Krasheninnikov A., Egorova E., Konyaeva E., Matveeva N.
|
| 卷 10, 编号 2 (2022) |
Economic damage of pneumococcal vaccination absence as a risk factor for complications of chronic obstructive pulmonary disease |
(Rus)
(Eng)
|
|
Orlova E., Dorfman I., Umerova A., Kantemirova B., Orlov M., Abdullaev M.
|
| 卷 10, 编号 2 (2022) |
Clinical and economic analysis of genetically engineered biologics consumption by patients with COVID-19 |
(Rus)
(Eng)
|
|
Petrov V., Ryazanova A., Ponomareva A., Shatalova O., Levina Y.
|
| 1 - 100 的 514 信息 |
1 2 3 4 5 6 > >> |
